Proxeon Biosystems receives investment for launch of new product  

Denmark's Proxeon Biosystems has received an undisclosed sum from the Danish Fund for Industrial Growth, Syddansk Venture and Vecata for new instrument launch

Proxeon Biosystems, a Funen based biotech company which develops and supplies products for proteomics research has received an investment from the Danish Fund for Industrial Growth, Syddansk Venture and Vecata. The financial details of the investment have not been disclosed. Proxeon Biosystems is ready to launch a newly developed instrument for protein analysis on the global biotech market.

The instrument, a nanoflow-HPLC (High Pressure Liquid Chromatography – Ed) is targeted at universities, clinicians and pharmaceutical companies which analyse large amounts of data on protein groups, also called proteomics. Proxeon Biosystems aims to launch the instrument initially in North American and Western Europe where the demand for the product is estimated to be around 2,000 instruments annually.

Proxeon Biosystems was founded in 2002. The company's core competencies are in mass spectrometry, protein analysis and design of hardware for laboratory use. In 2005, Proxeon Biosystems expects to generate revenues of DKK 20 mn (USD 3.4 mn). The news is reported by Industriens Dagblad.

Link > Proxeon Biosystems

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×